LFB Biomedicaments, 3.348% 31mar2026, EUR (FIGI BBG011C6XB35, FR00140039X1)
国内債券, Subordinated Unsecured
国内債券, Subordinated Unsecured
|
LFB Biomedicaments was incorporated in 1994. The company is a French biopharmaceutical group that develops, manufactures, and markets plasma-derived medicinal products and recombinant proteins for the treatment of serious and often rare diseases. Its therapeutic focus ...
LFB Biomedicaments was incorporated in 1994. The company is a French biopharmaceutical group that develops, manufactures, and markets plasma-derived medicinal products and recombinant proteins for the treatment of serious and often rare diseases. Its therapeutic focus includes immunology, haemostasis, and intensive care. The company is a subsidiary of the LFB Group, which is owned by the French State.
|
|
|
|
|
|
|
|
|
最も包括的なデータベースを探索
1 000 000
債券
80 234
株
175 910
ETF&投資信託
70 000
インデックス
最も効率的な方法でポートフォリオを追跡